about
Insulin, cognition, and dementiaGlucose dysregulation and response to common anti-diabetic agents in the FATZO/Pco mouse.Relationship between body mass index and insulin resistance in patients treated with second generation antipsychotic agents.Insulin resistance syndrome, body mass index and the risk of ischemic heart disease.Modulation of coronary heart disease risk by insulin resistance in subjects with normal glucose tolerance or prediabetes.Relationship among 25-hydroxyvitamin D concentrations, insulin action, and cardiovascular disease risk in patients with essential hypertension.Insulin, glucose, insulin resistance, and incident colorectal cancer in male smokers.Lipoprotein kinetics in the metabolic syndrome: pathophysiological and therapeutic lessons from stable isotope studiesGenetic view on the phenomenon of combined diseases in man.Study of the Use of Lipid Panels as a Marker of Insulin Resistance to Determine Cardiovascular RiskFeatures of the metabolic syndrome and the risk of cardiovascular disease.The role of membrane glycoprotein plasma cell antigen 1/ectonucleotide pyrophosphatase phosphodiesterase 1 in the pathogenesis of insulin resistance and related abnormalities.Does the association of the triglyceride to high-density lipoprotein cholesterol ratio with fasting serum insulin differ by race/ethnicity?The evolving definitions and increasing prevalence of the metabolic syndrome.Insulin resistance and hyperinsulinemia: you can't have one without the other.Type 2 diabetes and cardiovascular disease: getting to the fat of the matter.Tree-structured supervised learning and the genetics of hypertensionEffect of moderate alcoholic beverage consumption on insulin sensitivity in insulin-resistant, nondiabetic individualsInsulin resistance is associated with significant clinical atherosclerosis in nondiabetic patients with acute myocardial infarctionMeasurement of insulin-mediated glucose uptake: direct comparison of the modified insulin suppression test and the euglycemic, hyperinsulinemic clamp.Dyslipidaemia in the metabolic syndrome and type 2 diabetes: pathogenesis, priorities, pharmacotherapies.Emerging interface between metabolic syndrome and asthma.Adipokines and metabolic syndrome risk factors in women with previous gestational diabetes mellitus.Prevalence of metabolic syndrome in rural and urban Chinese population in Qingdao.Insulin resistance: The linchpin between prediabetes and cardiovascular disease.Fatty acid-induced mitochondrial uncoupling in adipocytes as a key protective factor against insulin resistance and beta cell dysfunction: a new concept in the pathogenesis of obesity-associated type 2 diabetes mellitus.A fully human, allosteric monoclonal antibody that activates the insulin receptor and improves glycemic control.Green tea extract decreases oxidative stress and improves insulin sensitivity in an animal model of insulin resistance, the fructose-fed rat.A1 adenosine receptor partial agonist lowers plasma FFA and improves insulin resistance induced by high-fat diet in rodents.Insulin Resistance and Alzheimer's Disease: Bioenergetic Linkages.
P2860
Q33604874-A09FA41F-47D9-4B12-AC3B-0904237AA415Q33825537-3C85AD80-C94B-44A2-A3C1-D63A8ABBFFC3Q33862577-51B4EE5C-8AAC-49AC-86AB-2FFC2E1FDC12Q33938941-298D14E7-9F88-4141-846E-E07E35B613A0Q34559762-E3212B0C-311F-46F2-8A62-7FDB2DE59C8AQ35171813-048A735D-FCF3-4812-961B-50C551537D30Q35578858-D8471F37-0357-4F16-A256-33CC2549732AQ35754362-39001F68-8E56-4CD3-B26F-3FAE51306AEEQ35944277-FEBC5D54-90AB-4F17-835D-82CF5453C050Q36224351-29CD182F-75A2-475E-B8A8-160BD4552E0AQ36317996-145E6B9E-01AC-4965-9FC9-57B9B0CA622EQ36463221-A8813427-F345-4E71-82F7-300D488CF483Q36539179-3CD4FD3E-23E5-4FAE-BF8A-BC6A0EEA6492Q36749236-F8C51249-C597-4F12-96C8-B53B5E928B57Q36756593-2B4B5AAF-17BF-40C8-9D42-936A95398E11Q36814772-FE8A0479-1DBB-4683-9F5E-021F897972B6Q36985878-C5706458-2322-4F9A-A93F-C66DE1B97C85Q37178602-F81AB83D-1916-414E-9D67-553DBA10D9F9Q37374628-446D2F8A-6D69-4956-841D-F9029B5482CFQ37586176-3EBB1F9B-34C6-487F-AB22-7DC4BC29EAB0Q37772510-9E832FFF-FC3E-474C-94DD-92AD1E4AB2A0Q37775434-E3926CF8-DBBF-4510-BBA6-C0FCD7BBCB18Q39624198-F7ED53A0-53CE-44F4-89AB-E7B95E748F7BQ39968195-F233805E-3A86-465B-A370-62181085EE71Q40956133-C1FB1715-B563-41A5-8203-5F4C62BC8AF3Q41899790-8CBA60F5-1C5B-4C05-AFFD-59303CA6E87DQ41922145-B6F7734D-919B-4C0D-9D20-283EDEB53E20Q43109203-7F77B715-F798-46CB-864F-8D424BEBC11DQ44754463-E1225425-6579-4281-BA5B-0BB98F06FEF8Q46799102-331917F0-055C-44CA-B838-41BE25E4337C
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The insulin resistance syndrome.
@ast
The insulin resistance syndrome.
@en
type
label
The insulin resistance syndrome.
@ast
The insulin resistance syndrome.
@en
prefLabel
The insulin resistance syndrome.
@ast
The insulin resistance syndrome.
@en
P2860
P1476
The insulin resistance syndrome.
@en
P2860
P2888
P304
P356
10.1007/S11883-003-0007-0
P577
2003-09-01T00:00:00Z